<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="adnfle" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">adnfle</book-part-id>
      <title-group>
        <title>Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</title>
        <alt-title alt-title-type="alt-title">Synonym: ADNFLE</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kurahashi</surname>
            <given-names>Hirokazu</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Aichi Medical University<break/>Nagakute, Japan</aff>
          <email>kurahashi.hirokazu.736@mail.aichi-med-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hirose</surname>
            <given-names>Shinichi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Fukuoka University<break/>Fukuoka, Japan</aff>
          <email>hirose@fukuoka-u.ac.jp</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>16</day>
          <month>5</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>19</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>23</day>
          <month>1</month>
          <year>2004</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="higes" document-type="chapter">Autosomal Dominant Hyper IgE Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="lad-ad" document-type="chapter">Autosomal Dominant Leukodystrophy with Autonomic Disease</related-object>
      <abstract id="adnfle.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is characterized by clusters of nocturnal motor seizures, which are often stereotyped and brief (5 seconds to 5 minutes). They vary from simple arousals from sleep to dramatic, often bizarre, hyperkinetic events with tonic or dystonic features. Affected individuals may experience aura. Retained awareness during seizures is common. A minority of individuals experience daytime seizures. Onset ranges from infancy to adulthood. About 80% of individuals develop ADNFLE in the first two decades of life; mean age of onset is ten years. Clinical neurologic examination is normal and intellect is usually preserved, but reduced intellect, psychiatric comorbidity, or cognitive deficits may occur. Within a family, the manifestations of the disorder may vary considerably. ADNFLE is lifelong but not progressive. As an individual reaches middle age, attacks may become milder and less frequent.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of ADNFLE is made on clinical grounds. A detailed history from the affected individual and witnesses, supplemented if necessary by video-EEG monitoring, is the key to diagnosis. Molecular genetic testing reveals pathogenic variants in <italic toggle="yes">CHRNA4</italic>, <italic toggle="yes">CHRNB2,</italic>
<italic toggle="yes">CHRNA2</italic>, <italic toggle="yes">KCNT1</italic>, <italic toggle="yes">DEPDC5</italic>, or <italic toggle="yes">CRH</italic> in approximately 20% of individuals with a positive family history and fewer than 5% of individuals with a negative family history.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Carbamazepine is associated with remission in about 70% of individuals, often in relatively low doses. Individuals with ADNFLE associated with the <italic toggle="yes">CHRNA4</italic> pathogenic variant p.Ser284Leu are more responsive to zonisamide than carbamazepine. Resistance to AEDs, present in about 30% of affected individuals, requires a trial of all appropriate AEDs. Vagal nerve stimulation may be considered for individuals resistant to AEDs.</p>
          <p><italic toggle="yes">Surveillance</italic>: Reevaluation of EEGs at regular intervals to monitor disease progression.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> A medical history from relatives at risk can identify those with ADNFLE so that treatment can be initiated promptly.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>ADNFLE is inherited in an autosomal dominant manner. Most individuals diagnosed with ADNFLE have an affected parent. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown, as the frequency of subtle signs of the disorder in parents has not been thoroughly evaluated and molecular genetic data are insufficient. Penetrance is estimated at 70% and the risk to each offspring of inheriting the pathogenic variant is 50%; thus, the chance that the offspring will manifest ADNFLE is (50% x 70%) 35%. Prenatal testing for pregnancies at increased risk is possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="adnfle.Diagnosis">
        <title>Diagnosis</title>
        <sec id="adnfle.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) <bold>should be suspected</bold> in individuals with</p>
          <list list-type="bullet">
            <list-item>
              <p>Clusters of seizures with a frontal semiology (see Note 1)</p>
            </list-item>
            <list-item>
              <p>Occurrence of seizures predominantly during sleep (see Note 1)</p>
            </list-item>
            <list-item>
              <p>Normal clinical neurologic examination</p>
            </list-item>
            <list-item>
              <p>Preserved intellect, although reduced intellect, cognitive deficits, or psychiatric comorbidity may occur</p>
            </list-item>
            <list-item>
              <p>Normal findings on neuroimaging</p>
            </list-item>
            <list-item>
              <p>Ictal EEG that may be normal or obscured by movement artifact</p>
            </list-item>
            <list-item>
              <p>Interictal EEG that shows infrequent epileptiform discharges</p>
            </list-item>
            <list-item>
              <p>Presence of the same disorder in other family members with evidence of an autosomal dominant mode of inheritance [<xref ref-type="bibr" rid="adnfle.REF.tassinari.1997">Tassinari &#x00026; Michelucci 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.combi.2004.923">Combi et al 2004</xref>]</p>
            </list-item>
          </list>
          <p>Note: (1) History of clusters of brief (5 seconds to 5 minutes) nocturnal motor seizures which are often stereotyped and may include nightmares, verbalizations, sudden limb movements, or other parasomnias (undesirable phenomena that occur mainly or only during sleep). The history may be obtained from the affected individual and witnesses, and supplemented if necessary by video-electroencephalogram (EEG) monitoring. (2) The clinical features of ADNFLE are indistinguishable from those of nonfamilial nocturnal frontal lobe epilepsy [<xref ref-type="bibr" rid="adnfle.REF.hayman.1997.969">Hayman et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.tenchini.1999.637">Tenchini et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.steinlein.2000.529">Steinlein et al 2000</xref>].</p>
        </sec>
        <sec id="adnfle.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of ADNFLE <bold>is established</bold> in a proband who has the clinical characteristics detailed above combined with a family history that is positive for other affected individuals and/or molecular genetic testing that detects a pathogenic variant in one of the six genes known to be associated with ADNFLE (see <xref ref-type="table" rid="adnfle.T.summary_of_molecular_genetic_te">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serial single-gene testing</bold> is based on the order in which pathogenic variants most commonly occur (i.e., <italic toggle="yes">CHRNA4</italic>, <italic toggle="yes">CHRNB2</italic>, <italic toggle="yes">KCNT1</italic>, <italic toggle="yes">DEPDC5</italic>, <italic toggle="yes">CHRNA2</italic>, and <italic toggle="yes">CRH</italic>).</p>
              <p>If no pathogenic variant is found, deletion/duplication analysis may be considered.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CHRNA4</italic>, <italic toggle="yes">CHRNB2</italic>, <italic toggle="yes">CHRNA2</italic>, <italic toggle="yes">KCNT1</italic>, <italic toggle="yes">DEPDC5</italic>, <italic toggle="yes">CRH</italic>, and other genes of interest (see <xref ref-type="sec" rid="adnfle.Genetically_Related_Allelic_Disor">Differential Diagnosis</xref>) may also be considered. Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of ADNFLE. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="adnfle.T.summary_of_molecular_genetic_te" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="3" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_1">ADNFLE Type</th>
                  <th id="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="3" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_2">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of ADNFLE Attributed to Mutation of This Gene</th>
                  <th id="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" rowspan="3" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4">Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3" id="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Family History</th>
                </tr>
                <tr>
                  <th headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1" id="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Positive</th>
                  <th headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1" id="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Negative&#x000a0;<sup>2</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">1</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">CHRNA4</italic>
                  </td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_1" rowspan="2" valign="middle" align="left" colspan="1">10%-20%&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_2" rowspan="2" valign="middle" align="left" colspan="1">Rare</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">3</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">CHRNB2</italic>
                  </td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_1" rowspan="2" valign="middle" align="left" colspan="1">Lower than in <italic toggle="yes">CHRNA4</italic>&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_2" rowspan="2" valign="middle" align="left" colspan="1">Rare&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">4</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">CHRNA2</italic>
                  </td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_1" rowspan="2" valign="middle" align="left" colspan="1">Rare&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_2" rowspan="2" valign="middle" align="left" colspan="1">Unknown</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">5</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">KCNT1</italic>
                  </td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_1" rowspan="2" valign="middle" align="left" colspan="1">&#x0003c;5%&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_2" rowspan="2" valign="middle" align="left" colspan="1">Unknown</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Unknown</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">DEPDC5</italic>
                  </td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_1" rowspan="2" valign="middle" align="left" colspan="1">10%&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_2" rowspan="2" valign="middle" align="left" colspan="1">Unknown</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Unknown</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">CRH</italic>
                  </td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_1" rowspan="2" valign="middle" align="left" colspan="1">Rare&#x000a0;<sup>11</sup></td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_2_1 hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_3_2" rowspan="2" valign="middle" align="left" colspan="1">Unknown</td>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adnfle.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="adnfle.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="adnfle" object-id="adnfle.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="adnfle.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="adnfle.TF.1.2">
                <label>2. </label>
                <p>The affected individual is a simplex case (i.e., a single occurrence in a family)</p>
              </fn>
              <fn id="adnfle.TF.1.3">
                <label>3. </label>
                <p>Approximately 20% of individuals with a family history have pathogenic variants in subunits of nicotinic acetylcholine receptor [<xref ref-type="bibr" rid="adnfle.REF.ottman.2010.655">Ottman et al 2010</xref>].</p>
              </fn>
              <fn id="adnfle.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="adnfle.TF.1.5">
                <label>5. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="adnfle.TF.1.6">
                <label>6. </label>
                <p>To date, exon or whole-gene deletions/duplications have not been detected in ADNFLE.</p>
              </fn>
              <fn id="adnfle.TF.1.7">
                <label>7. </label>
                <p>Reported in one individual [<xref ref-type="bibr" rid="adnfle.REF.liu.2011.94">Liu et al 2011</xref>]</p>
              </fn>
              <fn id="adnfle.TF.1.8">
                <label>8. </label>
                <p>Reported in one family [<xref ref-type="bibr" rid="adnfle.REF.aridon.2006.342">Aridon et al 2006</xref>]</p>
              </fn>
              <fn id="adnfle.TF.1.9">
                <label>9. </label>
                <p>[<xref ref-type="bibr" rid="adnfle.REF.heron.2012.1188">Heron et al 2012</xref>]</p>
              </fn>
              <fn id="adnfle.TF.1.10">
                <label>10. </label>
                <p>[<xref ref-type="bibr" rid="adnfle.REF.picard.2014.2101">Picard et al 2014</xref>]</p>
              </fn>
              <fn id="adnfle.TF.1.11">
                <label>11. </label>
                <p>Reported by one group [<xref ref-type="bibr" rid="adnfle.REF.combi.2005.899">Combi et al 2005</xref>, <xref ref-type="bibr" rid="adnfle.REF.sansoni.2013.e61306">Sansoni et al 2013</xref>]</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="adnfle.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="adnfle.Clinical_Description">
          <title>Clinical Description</title>
          <p>Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is characterized by clusters of nocturnal motor seizures with a range of manifestations.</p>
          <p><bold>Nocturnal seizures.</bold> Seizures may occur in any stage of sleep [<xref ref-type="bibr" rid="adnfle.REF.oldani.1996.964">Oldani et al 1996</xref>, <xref ref-type="bibr" rid="adnfle.REF.steinlein.1997.943">Steinlein et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>], although typically in clusters in non-REM (NREM) sleep, most commonly in stage 2 sleep [<xref ref-type="bibr" rid="adnfle.REF.oldani.1998.205">Oldani et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>]. The affected individual often goes back to sleep rapidly after a seizure, only to be awakened by another event.</p>
          <p>The seizures are often stereotyped and brief (5 seconds to 5 minutes). They vary from simple arousals from sleep to dramatic hyperkinetic events with tonic or dystonic features. The hyperkinetic manifestations may appear bizarre, sometimes with ambulation, bicycling movements, ballism (flinging or throwing arm movements), and pelvic thrusting movements.</p>
          <p>The three distinct sub-classifications of seizure types based on clinical features of the seizures (semiology) and their duration [<xref ref-type="bibr" rid="adnfle.REF.oldani.1998.205">Oldani et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>] are &#x0201c;paroxysmal arousals,&#x0201d; &#x0201c;paroxysmal dystonia,&#x0201d; and &#x0201c;episodic wandering.&#x0201d;</p>
          <list list-type="bullet">
            <list-item>
              <p>Paroxysmal arousal is characterized by abrupt recurrent arousals from NREM sleep associated with a stereotypic motor pattern.</p>
            </list-item>
            <list-item>
              <p>Paroxysmal dystonia is characterized by recurrent motor attacks with dystonic-dyskinetic features arising from NREM sleep and usually lasting less than two minutes.</p>
            </list-item>
            <list-item>
              <p>Episodic wandering means somnambulic agitated behavior arising from NREM sleep.</p>
            </list-item>
          </list>
          <p>The reported frequency ranges from one to 20 attacks each night, a mean of 20 seizures per month; about 60% of the patients reported more than 15 seizures per month [<xref ref-type="bibr" rid="adnfle.REF.oldani.1996.964">Oldani et al 1996</xref>, <xref ref-type="bibr" rid="adnfle.REF.thomas.1998.228">Thomas et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.nakken.1999.88">Nakken et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.ito.2000.52">Ito et al 2000</xref>, <xref ref-type="bibr" rid="adnfle.REF.picard.2000.1247">Picard et al 2000</xref>].</p>
          <p>Retained awareness during seizures is common and may cause affected individuals to fear falling asleep. A sense of difficulty breathing and hyperventilation may occur, as well as vocalization, clonic features, urinary incontinence, and secondary generalization.</p>
          <p>Some individuals experience an aura preceding the seizure during sleep and are aware of the onset. Aura may be nonspecific or may consist of numbness in one limb, fear, a shiver, vertigo, or a feeling of falling or being pushed.</p>
          <p>Note: A minority of individuals experience daytime seizures, typically during a period of poor seizure control. Some of the seizures reported are paroxysmal dystonia similar to those during sleep, and others are generalized tonic-clonic seizures, generalized atonic seizures, and focal seizures with impairment of consciousness or awareness [<xref ref-type="bibr" rid="adnfle.REF.oldani.1998.205">Oldani et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.picard.2014.2101">Picard et al 2014</xref>].</p>
          <p>
            <bold>EEG findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Ictal EEG recordings may be normal or may be obscured by movement artifact. Ictal rhythms, if present, are usually sharp waves or repetitive 8-11 Hz spikes. Recruiting patterns and rhythmic theta (bifrontal, unilateral frontal, or with diffuse desynchronization) are occasionally seen [<xref ref-type="bibr" rid="adnfle.REF.steinlein.1997.943">Steinlein et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.oldani.1998.205">Oldani et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.picard.2000.1247">Picard et al 2000</xref>]. <xref ref-type="bibr" rid="adnfle.REF.el_helou.2008.2201">El Helou et al [2008]</xref> suggest that seizures may be initiated by K-complexes.</p>
            </list-item>
            <list-item>
              <p>Interictal waking EEG shows anterior quadrant epileptiform activity in very few affected individuals.</p>
            </list-item>
            <list-item>
              <p>Interictal sleep EEG may show infrequent epileptiform discharges.</p>
            </list-item>
          </list>
          <p><bold>Cognitive findings.</bold> Clinical neurologic examination is normal and intellect is usually preserved [<xref ref-type="bibr" rid="adnfle.REF.oldani.1996.964">Oldani et al 1996</xref>, <xref ref-type="bibr" rid="adnfle.REF.nakken.1999.88">Nakken et al 1999</xref>]; however, in some individuals neuropsychological assessment reveals reduced intellect, cognitive deficits, or psychiatric comorbidity [<xref ref-type="bibr" rid="adnfle.REF.khatami.1998.809">Khatami et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.picard.2000.1247">Picard et al 2000</xref>, <xref ref-type="bibr" rid="adnfle.REF.cho.2003.1625">Cho et al 2003</xref>, <xref ref-type="bibr" rid="adnfle.REF.wood.2010.531">Wood et al 2010</xref>].</p>
          <p><xref ref-type="bibr" rid="adnfle.REF.picard.2009.354">Picard et al [2009]</xref> found below-normal general intellect in five (45%) of 11 subjects with special difficulty in executive tasks and concluded that cognitive dysfunction is an integral part of ADNFLE with nicotinic receptor mutation. It is suggested that certain neuronal nicotinic acetylcholine receptor (nAChR) pathogenic variants could be associated with an increased risk for such symptoms [<xref ref-type="bibr" rid="adnfle.REF.steinlein.2012.118">Steinlein et al 2012</xref>].</p>
          <p><xref ref-type="bibr" rid="adnfle.REF.magnusson.2003.91">Magnusson et al [2003]</xref> reported an increase in psychiatric symptoms in families with ADNFLE. Psychiatric and behavioral problems as well as intellectual disability are more common in the individuals with <italic toggle="yes">KCNT1</italic> pathogenic variants than in those with nAChR pathogenic variants [<xref ref-type="bibr" rid="adnfle.REF.heron.2012.1188">Heron et al 2012</xref>].</p>
          <p><bold>Familial variation.</bold> Within a family, the manifestations of the disorder may vary considerably [<xref ref-type="bibr" rid="adnfle.REF.hayman.1997.969">Hayman et al 1997</xref>]; individuals with subtle manifestations may not present for medical attention.</p>
          <p>A high incidence of true parasomnias (undesirable phenomena that occur mainly or only during sleep) has been reported in relatives of those with ADNFLE [<xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>]. True parasomnias were distinguished from epileptic seizures because of their age-dependent course, the rarity of episodes, and their being not violent and often not disturbing for the patient. They often ended well before the onset of the clear-cut epileptic seizures.</p>
          <p><bold>Onset and prognosis.</bold> ADNFLE is lifelong but not progressive. Onset ranges from infancy to adulthood. About 80% of affected individuals develop ADNFLE in the first two decades of life [<xref ref-type="bibr" rid="adnfle.REF.oldani.1998.205">Oldani et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.picard.2000.1247">Picard et al 2000</xref>]; mean age of onset is ten years. As an individual reaches middle age, attacks may become milder and less frequent. Seizures may vary over time; for example, tonic attacks appearing in early childhood may evolve into seizures with dystonic or hyperkinetic components in later childhood.</p>
        </sec>
        <sec id="adnfle.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><xref ref-type="bibr" rid="adnfle.REF.steinlein.2012.118">Steinlein et al [2012]</xref> suggested that certain nAchR pathogenic variants may be associated with an increased risk for cognitive dysfunction. Individuals with <italic toggle="yes">KCNT1</italic> pathogenic variants present a more severe phenotype than those with nAChR pathogenic variants, with lower age of onset, complete penetrance, and cognitive comorbidities [<xref ref-type="bibr" rid="adnfle.REF.heron.2012.1188">Heron et al 2012</xref>]. Marked intrafamilial variation in severity is seen, the reasons for which are unknown.</p>
        </sec>
        <sec id="adnfle.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is estimated at 70%. <italic toggle="yes">KCNT1</italic>-related ADNFLE demonstrates complete penetrance compared to 60-80% in nAChR-related ADNFLE.</p>
        </sec>
        <sec id="adnfle.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation has not been observed.</p>
        </sec>
        <sec id="adnfle.Prevalence">
          <title>Prevalence</title>
          <p>The number of families with ADNFLE reported exceeds 100 [<xref ref-type="bibr" rid="adnfle.REF.picard.2007">Picard &#x00026; Brodtkorb 2007</xref>], but no accurate data concerning the prevalence of ADNFLE exist. It is likely that the disorder is underdiagnosed, or in some cases misdiagnosed.</p>
          <p>Families with the disorder have been identified worldwide [<xref ref-type="bibr" rid="adnfle.REF.steinlein.2014.1">Steinlein 2014</xref>].</p>
        </sec>
      </sec>
      <sec id="adnfle.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">CHRNA4</italic>, <italic toggle="yes">CHRNB2</italic>, <italic toggle="yes">CHRNA2</italic>, and <italic toggle="yes">CRH.</italic></p>
        <p>Mutation of <italic toggle="yes">KCNT1</italic> is also associated with epilepsy with migrating focal seizures (EIMFS).</p>
        <p>Mutation of <italic toggle="yes">DEPDC5</italic> is associated with familial focal epilepsies including ADNFLE, familial temporal lobe epilepsy (FTLE), and familial focal epilepsy with variable foci (FFEVF) (see <xref ref-type="table" rid="adnfle.T.selected_depdc5_pathogenic_vari">Table 7</xref>). It is also identified in individuals with Rolandic epilepsy, unclassified focal childhood epilepsy, and focal epilepsy with cortical dysplasia. See <related-object link-type="booklink" source-id="gene" document-id="depdc5-epilepsy" document-type="chapter"><italic toggle="yes">DEPDC5</italic>-Related Epilepsy</related-object>.</p>
      </sec>
      <sec id="adnfle.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) includes conditions of varied etiology.</p>
        <p><bold>Normal sleep</bold> is characterized by periodic arousals, and occasionally other sleep-related movements or phenomena such as nightmares [<xref ref-type="bibr" rid="adnfle.REF.phillips.1998.1108">Phillips et al 1998</xref>].</p>
        <p><bold>Other parasomnias</bold> (disorders in which undesirable physical and mental phenomena occur mainly or exclusively during sleep [<xref ref-type="bibr" rid="adnfle.REF1">American Academy of Sleep Medicine 2014</xref>]) to be considered include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold><italic toggle="yes">Pavor nocturnus</italic> (night terrors)</bold>, a common childhood syndrome, is characterized by attacks of extreme fear and distress that occur one or two hours after the child falls asleep. The child is unaware during the attack, which lasts five to ten minutes, and is amnesic for the event the following day [<xref ref-type="bibr" rid="adnfle.REF.schenck.2000.145">Schenck &#x00026; Mahowald 2000</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Benign somnambulism (sleep walking)</bold> is not accompanied by abnormal motor behavior or dystonia and is usually a self-limiting disorder of childhood. Somnambulism is often familial.</p>
          </list-item>
        </list>
        <p><bold>Hysteria</bold> is often considered because the individual retains awareness during the attacks, which can be bizarre. Clues to the organic nature of attacks are the occurrence during sleep and the stereotyped semiology (sequence of observed events during the attack).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="pknd" document-type="chapter"><bold>Familial paroxysmal kinesigenic dyskinesia</bold></related-object> (familial PKD) is characterized by unilateral or bilateral involuntary movements precipitated by other sudden movements such as standing up from a sitting position, being startled, or changes in velocity; attacks include combinations of dystonia, choreoathetosis, and ballism, are sometimes preceded by an aura, and do not involve loss of consciousness. Attacks can be as frequent as 100 per day to as few as one per month. Duration of attacks is typically a few seconds to five minutes, but can be several hours. Familial PKD has been associated with infantile, but not adult-onset, seizures. Age of onset is typically in childhood and adolescence, but ranges from four months to 57 years. Familial PKD is predominantly seen in males.</p>
        <p>Pathogenic variants in <italic toggle="yes">PRRT2</italic> have been reported as causative of a subset of cases of familial PKD. The other gene(s) associated with PKD have not been identified. Inheritance is autosomal dominant.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="pnknd" document-type="chapter"><bold>Familial paroxysmal nonkinesigenic dyskinesia</bold></related-object> (familial PNKD) is characterized by unilateral or bilateral involuntary movements; attacks are spontaneous or precipitated by alcohol, coffee or tea, excitement, stress fatigue, or chocolate. Attacks involve dystonic posturing with choreic and ballistic movements, are sometimes accompanied by a preceding aura, occur while the individual is awake, and are not associated with seizures. Attacks last minutes to hours and rarely occur more than once per day. Age of onset is typically in childhood or early teens, but can be as late as age 50 years.</p>
        <p><italic toggle="yes">PNKD</italic>, the gene encoding myofibrillogenesis regulator 1, is the only gene known to be associated with familial PNKD. Inheritance is autosomal dominant.</p>
        <p><bold>Periodic limb movement disorder (nocturnal myoclonus)</bold> affects the flexor muscles of the lower limbs and is characterized by segmental motor activity in muscles that recurs every 20-30 seconds. Brief stationary movements may be followed by myoclonic or repetitive clonic jerks that coincide with the periodic K-complexes of light sleep.</p>
        <p><bold>Restless legs syndrome</bold> is often accompanied by segmental motor activity and may be a spinal cord-mediated disorder.</p>
        <p><bold>REM sleep disorders</bold> may include prominent motor and verbal manifestations that are often of unknown cause or secondary to other neurologic disorders. REM sleep disorders typically occur in men ages 55-60 years. Polysomnography is a useful diagnostic tool.</p>
        <p><bold>Respiratory disorders</bold> such as asthma may be considered because of difficulty breathing.</p>
        <p><bold>Obstructive sleep apnea</bold> may be considered in individuals complaining of daytime sleepiness who are not aware of their nocturnal attacks.</p>
      </sec>
      <sec id="adnfle.Management">
        <title>Management</title>
        <sec id="adnfle.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE):</p>
          <list list-type="bullet">
            <list-item>
              <p>In addition to the evaluation for epilepsy, cognitive and behavioral assessment to help determine the extent of disease</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="adnfle.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>In about 70% of individuals with ADNFLE, carbamazepine is associated with remission of seizures, often with relatively low doses. However, individuals with ADNFLE associated with the <italic toggle="yes">CHRNA4</italic> pathogenic variant <xref ref-type="table" rid="adnfle.T.selected_chrna4_pathogenic_vari">p.Ser284Leu</xref> respond only partially to carbamazepine and are more responsive to zonisamide [<xref ref-type="bibr" rid="adnfle.REF.provini.1999.1017">Provini et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.ito.2000.52">Ito et al 2000</xref>, <xref ref-type="bibr" rid="adnfle.REF.combi.2004.923">Combi et al 2004</xref>].</p>
          <p>Exposure to quinidine significantly reduces gain of function for <italic toggle="yes">KCNT1</italic> pathogenic variants implicated in ADNFLE and EIMFS [<xref ref-type="bibr" rid="adnfle.REF.milligan.2014.581">Milligan et al 2014</xref>]. Clinical treatment with quinidine was reported in a child with EIMFS [<xref ref-type="bibr" rid="adnfle.REF.bearden.2014.457">Bearden et al 2014</xref>], and correlated with a marked reduction in seizure frequency. In the future, it may be also possible to treat <italic toggle="yes">KCNT1</italic>-related ADNFLE with quinidine.</p>
          <p><bold>Resistance to AEDs</bold> occurs in about 30% of affected individuals. Intrafamilial variation in pharmaco-responsiveness occurs; therefore, all appropriate AEDs should be tried.</p>
          <p>Vagal nerve stimulation may be considered for individuals with resistance to AEDs [<xref ref-type="bibr" rid="adnfle.REF.carre_o.2010.155">Carre&#x000f1;o et al 2010</xref>].</p>
        </sec>
        <sec id="adnfle.Prevention_of_Secondary_Complicat">
          <title>Prevention of Secondary Complications</title>
          <p>Daytime complaints such as morning tiredness and somnolence may be caused by sleep fragmentation due to seizure-related arousals. To prevent this, it is important to provide diagnosis and treatment for ADNFLE appropriately.</p>
        </sec>
        <sec id="adnfle.Surveillance">
          <title>Surveillance</title>
          <p>Serial evaluation of EEGs to monitor disease progression is appropriate.</p>
        </sec>
        <sec id="adnfle.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment.</p>
          <list list-type="bullet">
            <list-item>
              <p>If the pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant in the family is not known, a medical history to seek evidence of affected status should be elicited from relatives at risk.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="adnfle.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="adnfle.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="adnfle.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="adnfle.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="adnfle.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with ADNFLE have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with ADNFLE may have the disorder as the result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">CHRNA4,</italic>
<italic toggle="yes">CHRNB2</italic>, <italic toggle="yes">CHRNA2</italic>, <italic toggle="yes">KCNT1, DEPDC5,</italic> or <italic toggle="yes">CRH</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown, as the frequency of subtle signs of the disorder in parents has not been thoroughly evaluated and molecular genetic data are insufficient. In one report a mother with a <italic toggle="yes">de novo</italic> pathogenic variant passed the condition on to her son [<xref ref-type="bibr" rid="adnfle.REF.phillips.2000.264">Phillips et al 2000</xref>].</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a child with nocturnal frontal lobe epilepsy and no known family history of NFLE include a detailed clinical and family history and molecular genetic testing (if the pathogenic variant in the proband has been identified).</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs and offspring of a proband depends on the genetic status of the parents:</p>
            </list-item>
            <list-item>
              <p>If one parent has phenotypic features of ADNFLE or has a pathogenic variant, the risk to each sib of inheriting the pathogenic variant is 50%. The chance that the sib will manifest ADNFLE is (50% x 70% =) 35%, assuming penetrance of 70%.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with ADNFLE has a 50% chance of inheriting the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The chance that the offspring will manifest ADNFLE is (50% x70% =) 35%, assuming penetrance of 70%.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> The risk to other family members depends on the genetic status of the proband's parents. If a parent is affected with ADNFLE or has the pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="adnfle.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="adnfle.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Other genetic counseling issues.</bold> Individuals may not be aware of the significance of their attacks; in some families, individuals may be reluctant to reveal their symptoms [<xref ref-type="bibr" rid="adnfle.REF.thomas.1998.228">Thomas et al 1998</xref>].</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="adnfle.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CHRNA4</italic>, <italic toggle="yes">CHRNB2</italic>, <italic toggle="yes">CHRNA2</italic>, <italic toggle="yes">KCNT1</italic>, <italic toggle="yes">DEPDC5</italic>, or <italic toggle="yes">CRH</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions regarding prenatal testing the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="adnfle.Resources">
        <title>Resources</title>
      </sec>
      <sec id="adnfle.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="adnfle.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The genes in which pathogenic variants are known to cause ADNFLE:</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">CHRNA4</italic>, encoding the &#x003b1;4 subunit of the neuronal nicotinic acetylcholine receptor (nAChR); associated with type 1 ADNFLE</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">CHRNB2,</italic> encoding the &#x003b2;2 subunit of the nAChR; associated with type 3 ADNFLE</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">CHRNA2,</italic> encoding &#x003b1;2 subunit of the nAChR; associated with type 4 ADNFLE</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">KCNT1,</italic> encoding a sodium-activated potassium channel; associated with type 5 ADNFLE</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">DEPDC5,</italic> encoding Dishevelled, Egl-10 and Pleckstrin (DEP) domain&#x02013;containing protein 5</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">CRH,</italic> encoding corticotropin-releasing hormone</p>
            </list-item>
          </list>
          <p>The neuronal nicotinic acetylcholine receptor is a heterologous pentamer comprising various combinations of alpha and beta subunits, encoded by <italic toggle="yes">CHRNA4</italic> and <italic toggle="yes">CHRNB2,</italic> respectively. The most common configuration is (&#x003b1;4)<sub>2</sub>(&#x003b2;2)<sub>3</sub> subunits; that is, two &#x003b1;4 and three &#x003b2;2 subunits.</p>
          <p>The receptor is widely distributed in the brain, including the frontal lobes. It is thought that the receptor is a presynaptic modulator of other neurotransmitter systems, including gamma-amino butyric acid (GABA), glutamate, and dopamine, and therefore may have variable effects on excitatory and inhibitory pathways [<xref ref-type="bibr" rid="adnfle.REF.kuryatov.1997.9035">Kuryatov et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.bertrand.1999.457">Bertrand 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.buisson.1999">Buisson et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.picard.1999.1198">Picard et al 1999</xref>].</p>
          <p>The second transmembrane domain of the receptor forms the ion channel pore and is the site of most of the pathogenic variants implicated in ADNFLE. Pathogenic variants in <italic toggle="yes">CHRNA4</italic> and <italic toggle="yes">CHRNB2</italic> associated with ADNFLE occur in highly conserved amino acids and alter the function of the resulting receptors.</p>
          <p>Functional studies of different pathogenic variants provide conflicting results although an increase in acetylcholine (Ach) sensitivity in vitro is typical for known ADNFLE-associated pathogenic variants [<xref ref-type="bibr" rid="adnfle.REF.kuryatov.1997.9035">Kuryatov et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.steinlein.1997.943">Steinlein et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.bertrand.1998.751">Bertrand et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.bertrand.1999.457">Bertrand 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.de_fusco.2000.275">De Fusco et al 2000</xref>, <xref ref-type="bibr" rid="adnfle.REF.phillips.2001.225">Phillips et al 2001</xref>, <xref ref-type="bibr" rid="adnfle.REF.di_corcia.2005.59">di Corcia et al 2005</xref>]; thus, the mechanism whereby the pathogenic variants cause ADNFLE is poorly understood.</p>
          <p>Sodium-activated potassium channel encoded by <italic toggle="yes">KCNT1</italic> is widely distributed in many regions of the mammalian brain, including the frontal cortex. Its activity contributes to the slow hyperpolarization that follows repetitive firing.</p>
          <p>Mutated channels with pathogenic variants identified in ADNFLE produce voltage-activated currents with higher magnitude compared to wild type, leading to gain of function.</p>
          <p>DEPDC5 is a component of GATOR1 (GTPase-actibating protein (GAP) activity toward RAGs complex 1) which negatively regulates mTORC1 (mammalian target of rapamycin complex 1), and expressed ubiquitously in human tissues. Most pathogenic variants are truncating variants that can be expected to result in nonsense-mediated mRNA degradation.</p>
          <p>The corticotropin-releasing hormone is widely distributed throughout the central nervous system. CRH acts as a neurotransmitter or neuromodulator in extrahypothalamic circuits to integrate a multisystem response to stress that controls numerous behaviors including sleep and arousal. Two new nucleotide variations in the promotor region were reported [<xref ref-type="bibr" rid="adnfle.REF.combi.2005.899">Combi et al 2005</xref>, <xref ref-type="bibr" rid="adnfle.REF.shimmin.2007.434">Shimmin et al 2007</xref>].</p>
          <sec id="adnfle.CHRNA4">
            <title>
              <italic toggle="yes">CHRNA4</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CHRNA4</italic> has six exons distributed over approximately 17 kb of genomic DNA [<xref ref-type="bibr" rid="adnfle.REF.steinlein.1996.289">Steinlein et al 1996</xref>]. The main part of the coding region is distributed in exon 5 [<xref ref-type="bibr" rid="adnfle.REF.steinlein.1996.289">Steinlein et al 1996</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="adnfle" object-id="adnfle.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> Benign variants of the <italic toggle="yes">CHRN</italic> receptor genes have been described [<xref ref-type="bibr" rid="adnfle.REF.weiland.1996.433">Weiland &#x00026; Steinlein 1996</xref>, <xref ref-type="bibr" rid="adnfle.REF.phillips.1997.135">Phillips &#x00026; Mulley 1997</xref>].</p>
            <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="adnfle.T.selected_chrna4_pathogenic_vari">Table 2</xref>. In a sporadic NFLE case, <xref ref-type="bibr" rid="adnfle.REF.chen.2009.152">Chen et al [2009]</xref> identified a novel variant in <italic toggle="yes">CHRNA4</italic> that causes an &#x003b1;4-Arg336His amino acid exchange outside the TM, and in the second intracellular loop between the third and fourth transmembrane domains. Certain pathogenic variants have been observed in many different countries; these pathogenic variants occurred independently [<xref ref-type="bibr" rid="adnfle.REF.steinlein.2000.529">Steinlein et al 2000</xref>, <xref ref-type="bibr" rid="adnfle.REF.hwang.2011.609">Hwang et al 2011</xref>].</p>
            <table-wrap id="adnfle.T.selected_chrna4_pathogenic_vari" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Selected <italic toggle="yes">CHRNA4</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.839C&#x0003e;T</td>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser280Phe&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/188035859">NM_000744.5</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4502827">NP_000735.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.851C&#x0003e;T</td>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser284Leu&#x000a0;<sup>2</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.878C&#x0003e;T</td>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr293Ile&#x000a0;<sup>3</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.870_872dupGCT</td>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu291dup&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1007G&#x0003e;A</td>
                    <td headers="hd_h_adnfle.T.selected_chrna4_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg336His&#x000a0;<sup>5</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="adnfle.TF.2.1">
                  <label>1. </label>
                  <p>Four families [<xref ref-type="bibr" rid="adnfle.REF.s_enz.1999.1004">S&#x000e1;enz et al 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.steinlein.2000.529">Steinlein et al 2000</xref>, <xref ref-type="bibr" rid="adnfle.REF.mclellan.2003.613">McLellan et al 2003</xref>]</p>
                </fn>
                <fn id="adnfle.TF.2.2">
                  <label>2. </label>
                  <p><xref ref-type="bibr" rid="adnfle.REF.hirose.1999.1749">Hirose et al [1999]</xref>, <xref ref-type="bibr" rid="adnfle.REF.rozycka.2003.1113">Rozycka et al [2003]</xref></p>
                </fn>
                <fn id="adnfle.TF.2.3">
                  <label>3. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.leniger.2003.981">Leniger et al [2003]</xref>
                  </p>
                </fn>
                <fn id="adnfle.TF.2.4">
                  <label>4. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.steinlein.1997.943">Steinlein et al [1997]</xref>
                  </p>
                </fn>
                <fn id="adnfle.TF.2.5">
                  <label>5. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.chen.2009.152">Chen et al [2009]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>For more information, see <related-object source-id="gene" document-id="adnfle" object-id="adnfle.molgen.TA">Table A</related-object>.</p>
            <p><bold>Normal gene product.</bold> Each nicotinic acetylcholine receptor subunit has a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region [<xref ref-type="bibr" rid="adnfle.REF.elliott.1996.217">Elliott et al 1996</xref>]. The &#x003b1; subunits are characterized by the presence of a pair of cysteine residues (Cys161 and Cys175, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4502827">NP_000735.1</ext-link>) that are presumed to function as part of the ACh binding site when the &#x003b1;4 subunits are complexed as a heterologous pentamer with the &#x003b2; subunits [<xref ref-type="bibr" rid="adnfle.REF.figl.1998.655">Figl et al 1998</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Functional studies of different pathogenic variants provide conflicting results, although an increase in ACh sensitivity in vitro is typical for known ADNFLE-causing pathogenic variants [<xref ref-type="bibr" rid="adnfle.REF.kuryatov.1997.9035">Kuryatov et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.steinlein.1997.943">Steinlein et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.bertrand.1998.751">Bertrand et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.bertrand.1999.457">Bertrand 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.de_fusco.2000.275">De Fusco et al 2000</xref>, <xref ref-type="bibr" rid="adnfle.REF.phillips.2001.225">Phillips et al 2001</xref>]; hence gain of function of nAChR may be a contributing mechanism of developing ADNFLE. Studies on mutated nAchR demonstrated an increased sensitivity to carbamazepine [<xref ref-type="bibr" rid="adnfle.REF.picard.1999.1198">Picard et al 1999</xref>].</p>
          </sec>
          <sec id="adnfle.CHRNB2">
            <title>
              <italic toggle="yes">CHRNB2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CHRNB2</italic> has six exons distributed over approximately 12 kb of genomic DNA. The main part of the coding region is distributed in exon 5. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="adnfle" object-id="adnfle.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> Benign variants of the <italic toggle="yes">CHRN</italic> receptor genes have been described [<xref ref-type="bibr" rid="adnfle.REF.weiland.1996.433">Weiland &#x00026; Steinlein 1996</xref>, <xref ref-type="bibr" rid="adnfle.REF.phillips.1997.135">Phillips &#x00026; Mulley 1997</xref>].</p>
            <p><bold>Pathogenic variants.</bold> Various pathogenic variants resulting in changes in the highly conserved region of the conducting pore or transmembrane domain are described. A novel variant in <italic toggle="yes">CHRNB2</italic>, p.Val337Gly, located between transmembrane domains M3 and M4, was identified in a sporadic NFLE case [<xref ref-type="bibr" rid="adnfle.REF.liu.2011.94">Liu et al 2011</xref>]. See <xref ref-type="table" rid="adnfle.T.selected_chrnb2_pathogenic_vari">Table 3</xref>.</p>
            <table-wrap id="adnfle.T.selected_chrnb2_pathogenic_vari" orientation="portrait" position="anchor">
              <label>Table 3. </label>
              <caption>
                <p>Selected <italic toggle="yes">CHRNB2</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.859G&#x0003e;C</td>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val287Leu&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_3" rowspan="7" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/110618251">NM_000748.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4502833">NP_000739.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.859G&#x0003e;T</td>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val287Leu&#x000a0;<sup>2</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.859G&#x0003e;A</td>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val287Met&#x000a0;<sup>3</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.901C&#x0003e;G</td>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu301Val&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.923T&#x0003e;C</td>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val308Ala&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.936C&#x0003e;G</td>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile312Met&#x000a0;<sup>5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1010T&#x0003e;G</td>
                    <td headers="hd_h_adnfle.T.selected_chrnb2_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val337Gly&#x000a0;<sup>6</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="adnfle.TF.3.1">
                  <label>1. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.de_fusco.2000.275">De Fusco et al [2000]</xref>
                  </p>
                </fn>
                <fn id="adnfle.TF.3.2">
                  <label>2. </label>
                  <p>Kurahashi et al [unpublished observation]</p>
                </fn>
                <fn id="adnfle.TF.3.3">
                  <label>3. </label>
                  <p><xref ref-type="bibr" rid="adnfle.REF.phillips.2001.225">Phillips et al [2001]</xref>, <xref ref-type="bibr" rid="adnfle.REF.d_azotero.2008.516">D&#x000ed;az-Otero et al [2008]</xref></p>
                </fn>
                <fn id="adnfle.TF.3.4">
                  <label>4. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.hoda.2008.379">Hoda et al [2008]</xref>
                  </p>
                </fn>
                <fn id="adnfle.TF.3.5">
                  <label>5. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.bertrand.2005.799">Bertrand et al [2005]</xref>
                  </p>
                </fn>
                <fn id="adnfle.TF.3.6">
                  <label>6. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.liu.2011.94">Liu et al [2011]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>For more information, see <related-object source-id="gene" document-id="adnfle" object-id="adnfle.molgen.TA">Table A</related-object>.</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">CHRNB2</italic> encodes the &#x003b2;2 subunit of nAChR. The &#x003b2;2 subunit is composed of 503 amino acids. <italic toggle="yes">CHRNB2</italic> is similar to <italic toggle="yes">CHRNA4</italic>, but the &#x003b2; subunits encoded by the genes are defined by the lack of paired cysteine residues [<xref ref-type="bibr" rid="adnfle.REF.elliott.1996.217">Elliott et al 1996</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Functional studies of different pathogenic variants provide conflicting results, although an increase in ACh sensitivity in vitro is typical for known ADNFLE-associated pathogenic variants [<xref ref-type="bibr" rid="adnfle.REF.kuryatov.1997.9035">Kuryatov et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.steinlein.1997.943">Steinlein et al 1997</xref>, <xref ref-type="bibr" rid="adnfle.REF.bertrand.1998.751">Bertrand et al 1998</xref>, <xref ref-type="bibr" rid="adnfle.REF.bertrand.1999.457">Bertrand 1999</xref>, <xref ref-type="bibr" rid="adnfle.REF.de_fusco.2000.275">De Fusco et al 2000</xref>, <xref ref-type="bibr" rid="adnfle.REF.phillips.2001.225">Phillips et al 2001</xref>]; hence, gain of function of nAChR may be a contributing mechanism of developing ADNFLE.</p>
          </sec>
          <sec id="adnfle.CHRNA2">
            <title>
              <italic toggle="yes">CHRNA2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CHRNA2</italic> has seven exons distributed over approximately 19 kb of genomic DNA. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="adnfle" object-id="adnfle.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> Benign variants of the <italic toggle="yes">CHRN</italic> receptor genes have been described [<xref ref-type="bibr" rid="adnfle.REF.weiland.1996.433">Weiland &#x00026; Steinlein 1996</xref>, <xref ref-type="bibr" rid="adnfle.REF.phillips.1997.135">Phillips &#x00026; Mulley 1997</xref>].</p>
            <p><bold>Pathogenic variants.</bold> One pathogenic variant resulting in changes in the highly conserved region of the first transmembrane domain is described [<xref ref-type="bibr" rid="adnfle.REF.aridon.2006.342">Aridon et al 2006</xref>]. See <xref ref-type="table" rid="adnfle.T.selected_chrna2_pathogenic_vari">Table 4</xref>.</p>
            <table-wrap id="adnfle.T.selected_chrna2_pathogenic_vari" orientation="portrait" position="anchor">
              <label>Table 4. </label>
              <caption>
                <p>Selected <italic toggle="yes">CHRNA2</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.836T&#x0003e;A</td>
                    <td headers="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile279Asn&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/157074211">NM_000742.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/153792669">NP_000733.2</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="adnfle.TF.4.1">
                  <label>1. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.aridon.2006.342">Aridon et al [2006]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">CHRNA2</italic> encodes the &#x003b1;2 subunit of nAChR. The &#x003b1;2 subunit is composed of 529 amino acids. <italic toggle="yes">CHRNA2</italic> is similar to <italic toggle="yes">CHRNA4</italic>.</p>
            <p><bold>Abnormal gene product.</bold> The <italic toggle="yes">CHRNA2</italic> pathogenic variant increases the receptor sensitivity to acetylcholine, and gain of function of nAChR may be a contributing mechanism of developing ADNFLE [<xref ref-type="bibr" rid="adnfle.REF.aridon.2006.342">Aridon et al 2006</xref>, <xref ref-type="bibr" rid="adnfle.REF.hoda.2009.1599">Hoda et al 2009</xref>]. Carbamazepine and oxcarbazepine produce a non-competitive channel inhibition in heteromeric neuronal nicotinic receptors including mutated &#x003b1;2 subunits as well as wild &#x003b1;2 subunits, but the different heteromeric nicotinic receptors exhibit distinct pharmacologic properties [<xref ref-type="bibr" rid="adnfle.REF.di_resta.2010.13">Di Resta et al 2010</xref>].</p>
          </sec>
          <sec id="adnfle.CRH">
            <title>
              <italic toggle="yes">CRH</italic>
            </title>
            <p><bold>Benign variants.</bold> Benign variants of <italic toggle="yes">CRH</italic> have been described [<xref ref-type="bibr" rid="adnfle.REF.shimmin.2007.434">Shimmin et al 2007</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="adnfle" object-id="adnfle.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Two variants in the promotor region and one missense variant were reported [<xref ref-type="bibr" rid="adnfle.REF.combi.2005.899">Combi et al 2005</xref>, <xref ref-type="bibr" rid="adnfle.REF.sansoni.2013.e61306">Sansoni et al 2013</xref>]. See <xref ref-type="table" rid="adnfle.T.selected_crh_pathogenic_variant">Table 5</xref>.</p>
            <table-wrap id="adnfle.T.selected_crh_pathogenic_variant" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p>Selected <italic toggle="yes">CRH</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.-365G&#x0003e;C&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">None&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000756.2">NM_000756.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.-669C&#x0003e;A&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">None&#x000a0;<sup>2</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.89C&#x0003e;G</td>
                    <td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro30Arg&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000756.2">NM_000756.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000747.1">NP_000747.1</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="adnfle.TF.5.1">
                  <label>1. </label>
                  <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/224589820">NC_000008.10</ext-link>:g.67090878C&#x0003e;G (GRCh37); <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=72556399">rs72556399</ext-link></p>
                </fn>
                <fn id="adnfle.TF.5.2">
                  <label>2. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.combi.2005.899">Combi et al [2005]</xref>
                  </p>
                </fn>
                <fn id="adnfle.TF.5.3">
                  <label>3. </label>
                  <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/224589820">NC_000008.10</ext-link>:g.67091182G&#x0003e;T (GRCh37); <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=12721510">rs12721510</ext-link></p>
                </fn>
                <fn id="adnfle.TF.5.4">
                  <label>4. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.sansoni.2013.e61306">Sansoni et al [2013]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">CRH</italic> is composed of 196 amino acids.</p>
            <p><bold>Abnormal gene product.</bold> In vitro assays demonstrated that these variants result in altered levels of gene expression. The luciferase assay showed stronger promotor activity for the c.-669C&#x0003e;A variation, whereas reduction of the promotor activity was detected for the c.-365G&#x0003e;C pathogenic variant [<xref ref-type="bibr" rid="adnfle.REF.combi.2005.899">Combi et al 2005</xref>].</p>
          </sec>
          <sec id="adnfle.KCNT1">
            <title>
              <italic toggle="yes">KCNT1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNT1</italic> has 31 exons distributed over approximately 90 kb of genomic DNA. There are two relevant transcript variants (the longer <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_020822.2">NM_020822.2</ext-link> and the alternate <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001272003.1">NM_001272003.1</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="adnfle" object-id="adnfle.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Various pathogenic variants resulting in changes in the highly conserved region are described. All of the variants are located within the intracellular region and most alter amino acids within or immediately adjacent to a nicotinamide adenine dinucleotide (NAD+)-binding site. They are identified in Australian (of British heritage), Italian, and Israeli families. See <xref ref-type="table" rid="adnfle.T.selected_kcnt1_pathogenic_varia">Table 6</xref>.</p>
            <table-wrap id="adnfle.T.selected_kcnt1_pathogenic_varia" orientation="portrait" position="anchor">
              <label>Table 6. </label>
              <caption>
                <p>Selected <italic toggle="yes">KCNT1</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1193G&#x0003e;A</td>
                    <td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg398Gln&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_020822.2">NM_020822.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_065873.2">NP_065873.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2386T&#x0003e;C</td>
                    <td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr796His&#x000a0;<sup>1</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2688G&#x0003e;A</td>
                    <td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met896Ile&#x000a0;<sup>1</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2782C&#x0003e;T</td>
                    <td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg928Cys&#x000a0;<sup>1</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="adnfle.TF.6.1">
                  <label>1. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.heron.2012.1188">Heron et al [2012]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">KCNT1</italic> (previously known as <italic toggle="yes">SLACK</italic>, <italic toggle="yes">SLO2.2</italic> and <italic toggle="yes">KCa4.1</italic>) encodes a sodium-activated potassium channel, and is composed of 1235 amino acids [<xref ref-type="bibr" rid="adnfle.REF.joiner.1998.462">Joiner et al 1998</xref>]. KCNT1 channel contains six putative membrane-spanning regions and extended C-terminus. The C-terminal cytoplasmic domain contains several motifs believed to interact with a protein network. One of the proteins is fragile X mental retardation protein (FMRP), which is a potent stimulator of <italic toggle="yes">KCNT1</italic> channel activity [<xref ref-type="bibr" rid="adnfle.REF.brown.2010.819">Brown et al 2010</xref>].</p>
            <p><bold>Abnormal gene product.</bold> The electrophysiologic properties of <italic toggle="yes">KCNT1</italic> variants identified in patients with ADNFLE were analyzed in vitro [<xref ref-type="bibr" rid="adnfle.REF.milligan.2014.581">Milligan et al 2014</xref>]. All of the variants studied (p.Met896Ile, p.Arg398Gln, p.Tyr796His, and p.Arg928Cys) increase current magnitude leading to gain of function, and in some cases hasten (p.Met896Ile, p.Arg928Cys) or slow (p.Arg398Gln) activation. The mechanisms underlying increased neuronal excitability due to a gain of function of the KCNT1 channels are not known.</p>
          </sec>
          <sec id="adnfle.DEPDC5">
            <title>
              <italic toggle="yes">DEPDC5</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">DEPDC5</italic> has 43 exons distributed over approximately 150 kb of genomic DNA. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="adnfle" object-id="adnfle.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> The majority of the <italic toggle="yes">DEPDC5</italic> pathogenic variants detected resulted in premature termination, suggesting haploinsufficiency as the disease mechanism. A certain <italic toggle="yes">DEPDC5</italic> variant (p.Trp1369Ter) was also found in a family with and familial focal epilepsy with variable foci (FFEVF) [<xref ref-type="bibr" rid="adnfle.REF.dibbens.2013.546">Dibbens et al 2013</xref>]. See <xref ref-type="table" rid="adnfle.T.selected_depdc5_pathogenic_vari">Table 7</xref>.</p>
            <table-wrap id="adnfle.T.selected_depdc5_pathogenic_vari" orientation="portrait" position="anchor">
              <label>Table 7. </label>
              <caption>
                <p>Selected <italic toggle="yes">DEPDC5</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2355-2A&#x0003e;G</td>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg785_Gly839del&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001242896.1">NM_001242896.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001229825.1">NP_001229825.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1459C&#x0003e;T</td>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg487Ter&#x000a0;<sup>1,&#x000a0;2</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3259C&#x0003e;T</td>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1087Ter&#x000a0;<sup>1</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4107G&#x0003e;A</td>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp1369Ter&#x000a0;<sup>1,&#x000a0;2,&#x000a0;3</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4567C&#x0003e;T</td>
                    <td headers="hd_h_adnfle.T.selected_depdc5_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln1523Ter&#x000a0;<sup>4</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn>
                  <p>Only pathogenic variants reported as a cause of ADNFLE are listed. Other pathogenic variants related to familial focal epilepsies could be also detected in ADNFLE.</p>
                </fn>
                <fn id="adnfle.TF.7.1">
                  <label>1. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.picard.2014.2101">Picard et al [2014]</xref>
                  </p>
                </fn>
                <fn id="adnfle.TF.7.2">
                  <label>2. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.dibbens.2013.546">Dibbens et al [2013]</xref>
                  </p>
                </fn>
                <fn id="adnfle.TF.7.3">
                  <label>3. </label>
                  <p>See <xref ref-type="sec" rid="adnfle.Genetically_Related_Allelic_Disor">Genetically Related Disorders</xref>.</p>
                </fn>
                <fn id="adnfle.TF.7.4">
                  <label>4. </label>
                  <p>
                    <xref ref-type="bibr" rid="adnfle.REF.ishida.2013.552">Ishida et al [2013]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> DEPDC5 is composed of 1603 amino acids and expressed ubiquitously in human tissues [<xref ref-type="bibr" rid="adnfle.REF.dibbens.2013.546">Dibbens et al 2013</xref>]. It contains a DEP homology domain which is present in many proteins of G-protein signaling pathways. DEPDC5 is a component of GATOR1 (GTPase-actibating protein (GAP) activity toward RAGs complex 1) which negatively regulates mTORC1 (mammalian target of rapamycin complex 1) [<xref ref-type="bibr" rid="adnfle.REF.barpeled.2013.1100">Bar-Peled et al 2013</xref>]. The mTOR pathway plays a role in many activities including cell growth, cell proliferation, and metabolism.</p>
            <p><bold>Abnormal gene product.</bold> Most pathogenic variants are truncating variants that can be expected to result in nonsense-mediated mRNA degradation. Aberrant mTORC1 signaling is known to cause disturbances in neuronal migration and cortical lamination, which has been demonstrated in neuronal migration disorders including tuberous sclerosis. Pathogenic variants in <italic toggle="yes">DEPDC5</italic> appear to have a less dramatic effect on mTORC1 signaling but disturb it sufficiently to develop focal epilepsy. Indeed, the phenotype of individuals with <italic toggle="yes">DEPDC5</italic> pathogenic variants extends with the identification of variants associated with Rolandic epilepsy, unclassified focal epilepsy [<xref ref-type="bibr" rid="adnfle.REF.lal.2014.788">Lal et al 2014</xref>], and focal epilepsy with brain malformations [<xref ref-type="bibr" rid="adnfle.REF.scheffer.2014.782">Scheffer et al 2014</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="adnfle.References">
        <title>References</title>
        <sec id="adnfle.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="adnfle.Literature_Cited.reflist0">
            <ref id="adnfle.REF1">
              <mixed-citation publication-type="web">American Academy of Sleep Medicine. <italic toggle="yes">International Classification of Sleep Disorders &#x02013; Third Edition (ICSD-3) Online Version</italic>. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.aasmnet.org/store/product.aspx?pid=849">for purchase</ext-link>. 2014.</mixed-citation>
            </ref>
            <ref id="adnfle.REF.aridon.2006.342">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aridon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Resta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brilli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Fusco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parrini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manfredi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pisano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruna</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cianchetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasqualetti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becchetti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>79</volume>
                <fpage>342</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">16826524</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.barpeled.2013.1100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bar-Peled</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chantranupong</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cherniack</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>W W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ottina</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabiner</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spear</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyerson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabatini</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1.</article-title>
                <source>Science</source>
                <volume>340</volume>
                <fpage>1100</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23723238</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.bearden.2014.457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bearden</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ehnot</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovine</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dlugos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <article-title>Targeted treatment of migrating partial seizures of infancy with quinidine.</article-title>
                <source>Ann Neurol.</source>
                <year>2014</year>
                <volume>76</volume>
                <fpage>457</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">25042079</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.bertrand.1999.457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Neuronal nicotinic acetylcholine receptors: their properties and alterations in autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Rev Neurol (Paris)</source>
                <volume>155</volume>
                <fpage>457</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">10472659</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.bertrand.2005.799">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmslie</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trounce</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits.</article-title>
                <source>Neurobiol Dis.</source>
                <volume>20</volume>
                <fpage>799</fpage>
                <lpage>804</lpage>
                <pub-id pub-id-type="pmid">15964197</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.bertrand.1998.751">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiland</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Br J Pharmacol</source>
                <volume>125</volume>
                <fpage>751</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">9831911</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.brown.2010.819">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kronengold</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gazula</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strumbos</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sigworth</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navaratnam</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarek</surname>
                    <given-names>LK</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack.</article-title>
                <source>Nat Neurosci</source>
                <volume>13</volume>
                <fpage>819</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">20512134</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.buisson.1999">
              <mixed-citation publication-type="book">Buisson B, Curtis L, Betrand D. Neuronal nicotinic acetylcholine receptor and epilepsy. In: Berkovic SF, Genton P, Hirsch E, Picard F, eds. <italic toggle="yes">Genetics of Focal Epilepsies.</italic> London, UK: John Libbey &#x00026; Co; 1999:187-202.</mixed-citation>
            </ref>
            <ref id="adnfle.REF.carre_o.2010.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carre&#x000f1;o</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Alvarez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maestro</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donaire</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boget</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumi&#x000e0;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pintor</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Setoain</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Malignant autosomal dominant frontal lobe epilepsy with repeated episodes of status epilepticus: successful treatment with vagal nerve stimulation</article-title>
                <source>Epileptic Disord</source>
                <volume>12</volume>
                <fpage>155</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20478764</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.chen.2009.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Q</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy.</article-title>
                <source>Epilepsy Res</source>
                <volume>83</volume>
                <fpage>152</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19058950</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.cho.2003.1625">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>YW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motamedi</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laufenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohn</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yi</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reba</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaillard</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesser</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>1625</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">14623738</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.combi.2005.899">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Combi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalpra</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferini-Strambi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenchini</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Frontal lobe epilepsy and mutations of the corticotropin-releasing hormone gene.</article-title>
                <source>Ann Neurol</source>
                <volume>58</volume>
                <fpage>899</fpage>
                <lpage>904</lpage>
                <pub-id pub-id-type="pmid">16222669</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.combi.2004.923">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Combi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalpra</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenchini</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferini-Strambi</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview.</article-title>
                <source>J Neurol</source>
                <volume>251</volume>
                <fpage>923</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">15316796</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.de_fusco.2000.275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Fusco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becchetti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patrignani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annesi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quattrone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanke</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy.</article-title>
                <source>Nat Genet</source>
                <volume>26</volume>
                <fpage>275</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11062464</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.d_azotero.2008.516">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D&#x000ed;az-Otero</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>del Mar Quesada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales-Corraliza</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Parra</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez-Garre</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serratosa</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene.</article-title>
                <source>Epilepsia</source>
                <volume>49</volume>
                <fpage>516</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">17900292</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.dibbens.2013.546">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donatello</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chintawar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crompton</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellows</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callenbach</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbett</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivity</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iona</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regan</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weller</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crimmins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero-Lopez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubeau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Licchetta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisulli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossette</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gecz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serratosa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brouwer</surname>
                    <given-names>OF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandolfo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Mutations in DEPDC5 cause familial focal epilepsy with variable foci.</article-title>
                <source>Nat Genet</source>
                <volume>45</volume>
                <fpage>546</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">23542697</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.di_corcia.2005.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>di Corcia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blasetti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Simone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verrotti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiarelli</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Recent advances on autosomal dominant nocturnal frontal lobe epilepsy: "understanding the nicotinic acetylcholine receptor (nAChR)</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <year>2005</year>
                <volume>9</volume>
                <fpage>59</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">15843070</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.di_resta.2010.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Resta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ambrosi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becchetti</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy.</article-title>
                <source>Eur J Pharmacol</source>
                <volume>643</volume>
                <fpage>13</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">20561518</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.el_helou.2008.2201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>El Helou</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fedirko</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>An-Gourfinkel</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adam</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>K-complex-induced seizures in autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Clin Neurophysiol.</source>
                <volume>119</volume>
                <fpage>2201</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18762450</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.elliott.1996.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elliott</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berckhan</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urrutia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chavez-Noriega</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velicelebi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harpold</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits.</article-title>
                <source>J Mol Neurosci</source>
                <volume>7</volume>
                <fpage>217</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">8906617</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.figl.1998.655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Figl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viseshakul</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shafaee</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsayeth</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>BN</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response.</article-title>
                <source>J Physiol</source>
                <volume>513</volume>
                <fpage>655</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">9824708</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.hayman.1997.969">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hayman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinvarun</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berlangieri</surname>
                    <given-names>SU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Autosomal dominant nocturnal frontal lobe epilepsy: demonstration of focal frontal onset and intrafamilial variation.</article-title>
                <source>Neurology</source>
                <volume>49</volume>
                <fpage>969</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">9339675</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.heron.2012.1188">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nobili</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahana</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Licchetta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliver</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazarib</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afawi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korczyn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plazzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Nat Genet</source>
                <volume>44</volume>
                <fpage>1188</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">23086396</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.hirose.1999.1749">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwata</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyoshi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsudome</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>1749</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">10563623</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.hoda.2008.379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoda</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonarakis</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goudie</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore.</article-title>
                <source>Mol Pharmacol.</source>
                <volume>74</volume>
                <fpage>379</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">18456869</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.hoda.2009.1599">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoda</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanischeck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene</article-title>
                <source>FEBS Lett</source>
                <volume>583</volume>
                <fpage>1599</fpage>
                <lpage>604</lpage>
                <pub-id pub-id-type="pmid">19383498</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.hwang.2011.609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurahashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>YW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Autosomal dominant nocturnal frontal lobe epilepsy: a genotypic comparative study of Japanese and Korean families carrying the CHRNA4 Ser284Leu mutation</article-title>
                <source>J Hum Genet</source>
                <volume>56</volume>
                <fpage>609</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">21753767</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.ishida.2013.552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ishida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolf</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>No&#x000e9;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Achaz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundwiller</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marescaux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miles</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leguern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Mutations of DEPDC5 cause autosomal dominant focal epilepsies.</article-title>
                <source>Nat Genet.</source>
                <year>2013</year>
                <volume>45</volume>
                <fpage>552</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23542701</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.ito.2000.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujii</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okuno</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwata</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsudome</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Electroclinical picture of autosomal dominant nocturnal frontal lobe epilepsy in a Japanese family.</article-title>
                <source>Epilepsia</source>
                <volume>41</volume>
                <fpage>52</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10643924</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.joiner.1998.462">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Joiner</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dworetzky</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boissard</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribkoff</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarek</surname>
                    <given-names>LK</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits.</article-title>
                <source>Nat Neurosci</source>
                <volume>1</volume>
                <fpage>462</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10196543</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.khatami.1998.809">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khatami</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolmel</surname>
                    <given-names>HW</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>A family with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation.</article-title>
                <source>J Neurol</source>
                <volume>245</volume>
                <fpage>809</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9840354</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.kuryatov.1997.9035">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuryatov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerzanich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olale</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindstrom</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors.</article-title>
                <source>J Neurosci</source>
                <volume>17</volume>
                <fpage>9035</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">9364050</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.lal.2014.788">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reinthaler</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schubert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muhle</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riesch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabbari</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawalia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holthausen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feucht</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neophytou</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haberlandt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altmuller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemke</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neubauer</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>DEPDC5 mutations in genetic focal epilepsies of childhood.</article-title>
                <source>Ann Neurol</source>
                <volume>75</volume>
                <fpage>788</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">24591017</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.leniger.2003.981">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leniger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kananura</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hufnagel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.</article-title>
                <source>Epilepsia.</source>
                <volume>44</volume>
                <fpage>981</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12823585</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.liu.2011.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ji</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lv</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>The identification of a novel mutation of nicotinic acetylcholine receptor gene CHRNB2 in a Chinese patient: Its possible implication in non-familial nocturnal frontal lobe epilepsy.</article-title>
                <source>Epilepsy Res.</source>
                <volume>95</volume>
                <fpage>94</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21497487</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.magnusson.2003.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Magnusson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stordal</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodtkorb</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations.</article-title>
                <source>Psychiatr Genet</source>
                <volume>13</volume>
                <fpage>91</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12782965</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.mclellan.2003.613">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McLellan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rittey</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkpatrick</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goudie</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephenson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolmie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuberi</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Phenotypic comparison of two Scottish families with mutations in different genes causing autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Epilepsia.</source>
                <volume>44</volume>
                <fpage>613</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12681012</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.milligan.2014.581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milligan</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gazina</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nair</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trager</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Younkin</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dlugos</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrovski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrou</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.</article-title>
                <source>Ann Neurol</source>
                <volume>75</volume>
                <fpage>581</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">24591078</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.nakken.1999.88">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakken</surname>
                    <given-names>KO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnusson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Autosomal dominant nocturnal frontal lobe epilepsy: an electroclinical study of a Norwegian family with ten affected members.</article-title>
                <source>Epilepsia</source>
                <volume>40</volume>
                <fpage>88</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">9924907</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.oldani.1998.205">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oldani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zucconi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asselta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Modugno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonati</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalpra</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcovati</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenchini</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smirne</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferini-Strambi</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Autosomal dominant nocturnal frontal lobe epilepsy. A video-polysomnographic and genetic appraisal of 40 patients and delineation of the epileptic syndrome.</article-title>
                <source>Brain</source>
                <volume>121</volume>
                <fpage>205</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">9549500</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.oldani.1996.964">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oldani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zucconi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferini-Strambi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bizzozero</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smirne</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Autosomal dominant nocturnal frontal lobe epilepsy: electroclinical picture.</article-title>
                <source>Epilepsia</source>
                <volume>37</volume>
                <fpage>964</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">8822695</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.ottman.2010.655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ottman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hrose</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopes-Cendes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noebels</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serratosa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Genetic testing in the epilepsies--report of the ILAE Genetics Commission.</article-title>
                <source>Epilepsia</source>
                <volume>51</volume>
                <fpage>655</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">20100225</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.phillips.2001.225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favre</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkpatrick</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuberi</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goudie</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>68</volume>
                <fpage>225</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11104662</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.phillips.2000.264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A de novo mutation in sporadic nocturnal frontal lobe epilepsy.</article-title>
                <source>Ann Neurol</source>
                <volume>48</volume>
                <fpage>264</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10939581</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.phillips.1997.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>SSCP variants within the alpha 4 subunit of the neuronal nicotinic acetylcholine receptor gene.</article-title>
                <source>Clin Genet</source>
                <volume>51</volume>
                <fpage>135</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9112007</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.phillips.1998.1108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crossland</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fish</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsden</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephenson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolmie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plazzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeg-Olofsson</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopes-Cendes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>1108</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">9758605</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.picard.2000.1247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahane</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebastianelli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigevano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gericke</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>An</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolf</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marescaux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families.</article-title>
                <source>Brain</source>
                <volume>123</volume>
                <fpage>1247</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">10825362</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.picard.1999.1198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine.</article-title>
                <source>Epilepsia</source>
                <volume>40</volume>
                <fpage>1198</fpage>
                <lpage>209</lpage>
                <pub-id pub-id-type="pmid">10487182</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.picard.2007">
              <mixed-citation publication-type="book">Picard F, Brodtkorb E. Familial frontal lobe epilepsies. In: Engel J, Pedley TA, eds. <italic toggle="yes">Epilepsy: A Comprehensive Textbook</italic>. 2 ed. Philadelphia, PA: Lippincott Williams &#x00026; Wilkins; 2007:2495-502.</mixed-citation>
            </ref>
            <ref id="adnfle.REF.picard.2014.2101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makrythanasis</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bellescize</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ville</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weckhuysen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fosselle</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suls</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasselon Raina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>An-Gourfinkel</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vlaicu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundwiller</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couarch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferini-Strambi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonarakis</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leguern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>82</volume>
                <fpage>2101</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24814846</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.picard.2009.354">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegna</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arntsberg</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarek</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Todica</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiriaco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodtkorb</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Neuropsychological disturbances in frontal lobe epilepsy due to mutated nicotinic receptors.</article-title>
                <source>Epilepsy Behav.</source>
                <volume>14</volume>
                <fpage>354</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19059498</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.provini.1999.1017">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Provini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plazzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinuper</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lugaresi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases.</article-title>
                <source>Brain</source>
                <volume>122</volume>
                <fpage>1017</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">10356056</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.rozycka.2003.1113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rozycka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skorupska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kostyrko</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trzeciak</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Epilepsia</source>
                <volume>44</volume>
                <fpage>1113</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12887446</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.s_enz.1999.1004">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gal&#x000e1;n</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caloustian</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenzo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e1;rquez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jim&#x000e9;nez</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poza</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobo</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grid</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prud'homme</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene.</article-title>
                <source>Arch Neurol.</source>
                <year>1999</year>
                <volume>56</volume>
                <fpage>1004</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10448807</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.sansoni.2013.e61306">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sansoni</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forcella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mozzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fusi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ambrosini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferini-Strambi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combi</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Functional characterization of a CRH missense mutation identified in an ADNFLE family.</article-title>
                <source>PLoS One</source>
                <volume>8</volume>
                <fpage>e61306</fpage>
                <pub-id pub-id-type="pmid">23593457</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.scheffer.2014.782">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regan</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandelstam</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crompton</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Licchetta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Provini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisulli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vadlamudi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gecz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connelly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinuper</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricos</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.</article-title>
                <source>Ann Neurol.</source>
                <year>2014</year>
                <volume>75</volume>
                <fpage>782</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">24585383</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.schenck.2000.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schenck</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahowald</surname>
                    <given-names>MW</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Parasomnias. Managing bizarre sleep-related behavior disorders.</article-title>
                <source>Postgrad Med</source>
                <volume>107</volume>
                <fpage>145</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">10728141</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.shimmin.2007.434">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimmin</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natarajan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ibarguen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montasser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanis</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerwinkle</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wadhwa</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hixson</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Corticotropin releasing hormone (CRH) gene variation: comprehensive resequencing for variant and molecular haplotype discovery in monosomic hybrid cell lines.</article-title>
                <source>DNA Seq</source>
                <volume>18</volume>
                <fpage>434</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">17676473</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.steinlein.2014.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Genetic heterogeneity in familial nocturnal frontal lobe epilepsy.</article-title>
                <source>Prog Brain Res</source>
                <volume>213</volume>
                <fpage>1</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">25194481</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.steinlein.2012.118">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoda</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Mutations in familial nocturnal frontal lobe epilepsy might be associated with distinct neurological phenotypes</article-title>
                <source>Seizure</source>
                <volume>21</volume>
                <fpage>118</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">22036597</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.steinlein.1997.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnusson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoodt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiland</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakken</surname>
                    <given-names>KO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propping</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>943</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9175743</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.steinlein.2000.529">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoodt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodtkorb</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Independent occurrence of the CHRNA4 Ser248Phe mutation in a Norwegian family with nocturnal frontal lobe epilepsy.</article-title>
                <source>Epilepsia</source>
                <volume>41</volume>
                <fpage>529</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">10802757</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.steinlein.1996.289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiland</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoodt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propping</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Exon-intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4).</article-title>
                <source>Genomics</source>
                <volume>32</volume>
                <fpage>289</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">8833159</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.tassinari.1997">
              <mixed-citation publication-type="book">Tassinari CA, Michelucci R. Familial frontal and temporal lobe epilepsy. In: Engel JJ, Pedley TA, eds. <italic toggle="yes">Epilepsy: A Comprehensive Textbook.</italic> Philadelphia, PA: Lippincott-Raven Publishers; 1997:2427-31.</mixed-citation>
            </ref>
            <ref id="adnfle.REF.tenchini.1999.637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tenchini</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonati</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asselta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zucconi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcovati</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalpra</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferini-Strambi</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>SER252PHE and 776INS3 mutations in the CHRNA4 gene are rare in the Italian ADNFLE population.</article-title>
                <source>Sleep</source>
                <volume>22</volume>
                <fpage>637</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10450598</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.thomas.1998.228">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chatel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marescaux</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Autosomal dominant nocturnal frontal lobe epilepsy.</article-title>
                <source>Rev Neurol (Paris)</source>
                <volume>154</volume>
                <fpage>228</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">9773047</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.weiland.1996.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weiland</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Dinucleotide polymorphism in the first intron of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4).</article-title>
                <source>Clin Genet</source>
                <volume>50</volume>
                <fpage>433</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9007339</pub-id>
              </element-citation>
            </ref>
            <ref id="adnfle.REF.wood.2010.531">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saling</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fedi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benjamin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reutens</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Neuropsychological function in patients with a single gene mutation associated with autosomal dominant nocturnal frontal lobe epilepsy</article-title>
                <source>Epilepsy Behav</source>
                <volume>17</volume>
                <fpage>531</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20189461</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="adnfle.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="adnfle.Author_History">
          <title>Author History</title>
          <p>Judith Adams, MBBS, FRACP; University of Melbourne (2002-2004)
Samuel F Berkovic, MD, FRACP; Epilepsy Research Institute (2002-2010) Shinichi Hirose, MD, PhD (2010-present)Hirokazu Kurahashi, MD, PhD (2010-present)Ingrid E Scheffer, MBBS, FRACP, PhD; Austin and Repatriation Medical Centre (2002-2010)</p>
        </sec>
        <sec id="adnfle.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>19 February 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 September 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 April 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>24 June 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>23 January 2004 (cd) Revision: mutation detection rate</p>
            </list-item>
            <list-item>
              <p>16 May 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>22 January 2002 (ja) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
